Stevens-Johnson induced by imiquimod 5% cream: a case report

Abstract

Imiquimod 5% cream is an approved treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. Severe systemic side effects associated to imiquimod 5% cream are rare, although few cases of erythema multiforme and Stevens-Johnson syndrome have been described. We present a case of Stevens-Johnson syndrome associated to topical treatment with imiquimod of two superficial basal cell carcinomas.

Keywords

• Imiquimod
• Stevens-Johnson syndrome
• adverse drug reaction